Bullfrog AI Holdings, Inc. Common Stock
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Open BFRG dashboard ↗PDF Solutions Inc
PDF Solutions, Inc. provides proprietary software, physical intellectual property for integrated circuit designs, electrical measurement hardware tools, proven methodologies, and professional services in the United States, Japan, China, Taiwan, and internationally. The company offers Exensio software products, such as Manufacturing Analytics, a proprietary database schema to store collected data to identify and analyze production yield, performance, reliability, and other issues; Process Control, which provides failure detection and classification capabilities for monitoring, alarming, and controlling manufacturing tool sets; Test Operations that offer data collection and analysis capabilities; and Assembly Operations that provide device manufacturers with the capability to link assembly and packaging data, including fabrication and characterization data over the product life cycle. It also provides Sapience Manufacturing Hub enterprise, a connectivity platform between enterprise applications; Design-For-Inspection (DFI) systems, such as Proprietary Software, DFI On-Chip Instruments, eProbe Non-Contact E-Beam Tool; and Characterization Vehicle (CV) system, which includes CV Test Chips and pdFasTest Electrical Tester, as well as Exensio characterization software. In addition, the company offers Cimetrix software products that enable equipment manufacturers to provide standard interfaces on their products for equipment communication, control, and data collection; equipment factory connectivity products, such as Cimetrix CIMConnect, Cimetrix CIM300, and Cimetrix CIMPortal Plus; and equipment factory connectivity testing and equipment control products, as well as software-as-a-service, software related services, DFI system related services, and characterization services. PDF Solutions, Inc. was founded in 1991 and is headquartered in Santa Clara, California.
Open PDFS dashboard ↗